Hexagon Nutrition Ltd (MAINBOARD)

MainboardClosed

Min. Investment

₹14,985

/ 333 Shares

Check Allotment Status

Issue Price

42-45

Subscription

4.60x

Issue Size

138.87

Lot Size

333

Open

Jun 5, 2026

Jun 9, 2026

Allotment

Jun 10, 2026

Listing

Jun 12, 2026

1. Hexagon Nutrition Ltd (MAINBOARD) IPO Details

Hexagon Nutrition Ltd IPO Details

Hexagon Nutrition Ltd IPO is a book-built issue of ₹138.87 crores. The issue consists entirely of an Offer for Sale (OFS) of 3.09 crore shares, with no fresh issue component.

The bidding for the IPO started this Friday, Jun 5, 2026, and ends on Jun 9, 2026. The allotment is expected to be finalized on Jun 10, 2026. The company will list on both the BSE and NSE mainboard platforms, with a tentative listing date fixed as Jun 12, 2026.

The price band is set at ₹42–₹45 per share. The lot size for an application is 333 shares, which is also the minimum application for retail investors. The minimum amount of investment required by a retail investor is ₹14,985.

Grey Market Premium

Estimated listing gains (Live)

+2.75 (6.1%)Per Share

EST. GAINS

Updated real-time from market sources

Financial Summary

Period Ended	31 Dec 2025	31 Mar 2025	31 Mar 2024	31 Mar 2023
Assets	327.60	261.36	250.54	288.90
Total Income	275.57	331.29	304.62	281.65
Profit After Tax	27.03	24.38	12.21	5.82
EBITDA	37.55	40.07	24.88	17.17
NET Worth	223.05	195.60	176.29	163.84
Reserves and Surplus	210.92	183.89	164.51	152.30
Total Borrowing	39.79	26.60	36.89	51.87

IPO Details

IPO Date	5 to 9 Jun, 2026
Listing Date	Fri, Jun 12, 2026 T
Face Value	₹ 1 per share
Price Band	₹42 to ₹45
Lot Size	333 Shares
Sale Type	OFS only
Issue Type	Bookbuilding IPO
Listing At	BSE, NSE
Total Issue Size	3,08,59,704 shares (agg. up to ₹ 139 Cr)
Offer for Sale	3,08,59,704 shares of ₹ 1 (agg. up to ₹ 139 Cr)
Share Holding Pre Issue	12,29,18,109 shares
Share Holding Post Issue	12,29,18,109 shares

Issue Reservation

Investor Category	Shares Offered	% of Total Issue	Max Allottees
QIB Shares Offered	1,54,29,852	50.00%	NA
− Anchor Investor Shares Offered	92,57,696	30.00%	NA
− QIB (Ex. Anchor) Shares Offered	61,72,156	20.00%	NA
NII (HNI) Shares Offered	46,28,956	15.00%	NA
− bNII > ₹10L	30,85,970	10.00%	661
− sNII < ₹10L	15,42,985	5.00%	330
Retail Shares Offered	1,08,00,896	35.00%	32,435
Total Shares Offered	3,08,59,704	100.00%

IPO Lot Size

Application	Lots	Shares	Amount
Retail (Min)	1	333	₹14,985
Retail (Max)	13	4,329	₹1,94,805
S-HNI (Min)	14	4,662	₹2,09,790
S-HNI (Max)	66	21,978	₹9,89,010
B-HNI (Min)	67	22,311	₹10,03,995

IPO Anchor Investors

Bid Date	Thu, Jun 4, 2026
Shares Offered	92,57,696
Anchor Portion (₹ Cr.)	41.66
Anchor lock-in period end date for 50% shares (30 Days)	Fri, Jul 10, 2026
Anchor lock-in period end date for remaining shares (90 Days)	Tue, Sep 8, 2026

Recently Listed IPOs in Pharmaceuticals & Biotechnology

Company	Issue Type	Issue Size	Issue Price	Listing Day Close	Listing Gain/Loss %	LTP
Sai Parenteral's Ltd.	Mainboard	₹408.79 Cr	₹392	₹405.70	+3.49%	₹545.20 ( -0.33% )
Corona Remedies Ltd.	Mainboard	₹655.37 Cr	₹1062	₹1,438.40	+35.44%	₹1,725.00 ( +1.22% )
Rubicon Research Ltd.	Mainboard	₹1,377.68 Cr	₹485	₹628.20	+29.53%	₹1,202.50 ( -7.29% )

Key Performance Indicator (KPI)

KPI	Dec 31, 2025	Mar 31, 2025
ROE	13.02%	10.47%
ROCE	14.82%	17.06%
Debt/Equity	0.18	0.14
RoNW	12.12%	12.46%
PAT Margin	9.81%	7.36%
EBITDA Margin	14.03%	12.33%
Price to Book Value	2.48	2.83

Pre/Post IPO Valuation

Parameter	Pre IPO	Post IPO
EPS (₹)	1.98	2.93
P/E (x)	22.69	15.35
Promoter Holding	89.41%	64.29%
Market Cap	₹ 553.13 Cr.	-

Hexagon Nutrition IPO Recommendations

Review By	Subscribe	May Apply	Neutral	Avoid
Brokers	4	1	3	0
Members	0	0	0	1

IPO Subscription Status

Category	Subscription (x)	Shares Offered	Shares bid for
QIB (Ex Anchor)	0.17	61,72,156	10,36,629
NII	6.70	46,28,956	3,10,34,601
bNII (> ₹10L)	5.04	30,85,970	1,55,63,088
sNII (< ₹10L)	10.03	15,42,985	1,54,71,513
Retail	6.22	1,08,00,896	6,72,05,727
Total	4.60	2,16,02,008	9,92,76,957

2. About Hexagon Nutrition Ltd (MAINBOARD)

About Hexagon Nutrition Ltd

Incorporated in 1993, Hexagon Nutrition Limited is a research-driven, product-development-oriented nutrition company. The company manufactures and markets a wide range of nutritional products, micronutrient premixes, and clinical nutrition products designed to address global malnutrition and wellness needs.

Business Verticals

Branded Wellness & Clinical Nutrition (B2C): Manufacturing therapeutic formulations and health brands like Pentasure, Obesigo, Pediagold, and Nutrone, distributed via retail pharmacies and hospital networks.
Premix Formulations (B2B2C): Developing customized vitamin and mineral premixes supplied to food manufacturing giants for food fortification.
Ready-to-Use Foods & Micronutrient Powders: Supplying specialized therapeutic foods (RUFs) and micronutrient formulations for global ESG-focused food distribution initiatives.
Global Export Footprint: Operates across an omnichannel domestic network alongside an international export presence that reaches over 75 countries across Asia, Africa, Europe, and South America.

Track Record

Revenue Growth: Total income increased steadily from ₹281.65 Cr in FY23 to ₹331.29 Cr in FY25, reporting ₹275.57 Cr for the 9-month period ending December 2025.
Profitability: Net profit (PAT) nearly doubled from ₹12.21 Cr in FY24 to ₹24.38 Cr in FY25, and reached ₹27.03 Cr during the period ending December 2025.
Operational Scale: The company operates four advanced manufacturing facilities, including two strategically placed SEZ-based units in Chennai and Thoothukudi, along with an international unit in Tashkent, Uzbekistan.
Anchor Interest: The company raised ₹41.66 crore via its Anchor Investor allocation on June 4, 2026, locked in at the upper price band of ₹45 per share.

Hexagon Nutrition Ltd IPO GMP

As of June 8, 2026, the Grey Market Premium (GMP) is trading around ₹12.

Note: With a steady double-digit premium, the grey market signals a potential listing gain of approximately 26.7%, indicating an estimated listing price of around ₹57 against the upper issue price of ₹45.

Hexagon Nutrition Ltd IPO Allotment Status

The allotment is scheduled to be finalized on June 10, 2026.

Check Hexagon Nutrition Allotment Status

To check your status online, visit: KFin Technologies IPO Status Portal

You can verify your status via:

Registrar's website (KFin Technologies Limited)
BSE and NSE official portals
Using your PAN number, Application ID, or DP ID/Client ID

Strengths

Established Brand & Brand Recall: Strong market presence through well-known clinical nutrition brands like Pentasure and Obesigo.
Robust Export Infrastructure: Extensive logistics benefits from SEZ manufacturing sites, driving export scale across multiple continents.
Strong Financial Performance: Low financial leverage with a debt-to-equity ratio of just 0.18, backed by exceptional PAT growth in FY25.
Diverse Product Application: Caters to both mass-market nutritional fortification (B2B) and critical medical care pipelines (B2C).

Weaknesses

Pure Offer for Sale (OFS): The company will not receive any proceeds from the ₹138.87 crore raised, as the entire capital goes directly to the selling shareholders.
Raw Material Volatility: Margins remain exposed to severe price fluctuations of global raw ingredients like high-grade vitamins, minerals, and dairy derivatives.
Regulatory & Compliance Risks: Highly sensitive to food safety norms, FSSAI regulations, and statutory compliance certifications across different international jurisdictions.

How the Company Will Use IPO Money

Since the issue is structured entirely as an Offer for Sale (OFS), Hexagon Nutrition Limited will not receive any direct proceeds from the IPO. The core objectives of the offer are to:

Achieve the corporate benefits of listing equity shares on the stock exchanges.
Provide a liquidity avenue for existing selling promoters and investors.
Enhance overall corporate brand visibility and public market footprint.

Lead Manager & Registrar

Lead Managers: Cumulative Capital Private Limited and Catalyst Capital Partners Private Limited
Registrar: KFin Technologies Limited
Website: https://ipostatus.kfintech.com/

SEO Expert & Founder

DIPAK DANGODARA

I am a Digital Marketing professional with over 2+ years of experience, specializing in SEO and organic growth strategies. Over the years, I have worked with multiple businesses across different industries, helping them improve online visibility, traffic, and search rankings through data-driven and result-oriented SEO practices.

As the founder and owner of this website, I have launched my 2nd digital platform focused on the Indian stock market IPO segment. This platform provides detailed and reliable information on upcoming and ongoing IPOs in India, including IPO issue details, subscription status, live Grey Market Premium (GMP), and IPO allotment status, helping investors stay informed with accurate and timely IPO insights.